Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Stephanie Anne Learoyd has worked on the following 63 EPO patent applications which have been published in the last five years:

EP11785351

METHOD OF TREATMENT BASED ON ATAD2 INHIBITORS

IPC classification:
A61K 31/713, A61P 29/00, A61P 37/00, C12N 9/14, C12N 15/113, C12Q 1/34
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11791249

INHIBITORS OF SP140 AND THEIR USE IN THERAPY

IPC classification:
A61K 31/713, A61P 29/00, A61P 35/00, A61P 37/06, C12N 15/113
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
The patent has been granted
EP12702947

C-17 AND C-3 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/56, A61P 31/18, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12822366

CHEMICAL COMPOUNDS

IPC classification:
A61K 31/4178, C07D 403/14
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12727669

TUMOUR NECROSIS FACTOR RECEPTOR 1 ANTAGONISTS

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12824263

AMINO QUINAZOLINES AS KINASE INHIBITORS

IPC classification:
A61K 31/535
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP12766825

NOVEL BETULINIC ACID DERIVATIVES WITH ANTIVIRAL ACTIVITY

IPC classification:
A61K 31/56, A61P 31/18, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP11732087

TREATMENT METHOD

IPC classification:
A61K 31/52
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11742730

DERIVATIVES OF BETULIN

IPC classification:
A01N 45/00, A61K 31/50, A61K 31/56
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12826268

COMBINATION TREATMENTS FOR HEPATITIS C

IPC classification:
A01N 37/18, A01N 43/38, A61K 31/40, A61P 1/16
Applicant:
GlaxoSmithKline LLC
Agent:
Cornelis Marinus Jansen, Vereenigde Octrooibureaux NV (V.O.)
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12844715

PAZOPANIB FORMULATION

IPC classification:
A01N 43/40
Applicant:
GlaxoSmithKline Intellectual Property Limited
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Intellectual Property Management Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Markus Gruber, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13738466

COMPOSITIONS AND METHODS FOR TREATING DIABETES AND/OR OBESITY

IPC classification:
A01N 43/04, A61K 38/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13707493

C-3 CYCLOALKENYL TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/575, A61K 31/58, A61P 31/18, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13705712

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/4375, A61P 31/18, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP12857774

DERIVATIVES OF BETULIN

IPC classification:
C07C 69/753
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12856832

PROPENOATE DERIVATIVES OF BETULIN

IPC classification:
C07C 69/753
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13710940

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP13710240

FUSED PYRIMIDINES AS INHIBITORS OF IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP12824599

THERAPEUTIC METHODS

IPC classification:
A01N 55/08, A61K 31/69, A61P 31/12
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11722776

BIOMARKERS

IPC classification:
C12Q 1/68
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13722947

C-17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/56, A61P 31/18, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13750479

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 487/16, C07D 498/16
Applicant:
Bristol-Myers Squibb Company
Agent:
Regina Vögeli-Lange, Swords Laboratories
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP13759172

INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/7105, G01N 1/00
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13863026

PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 31/568, A61P 31/18, C07C 69/74, C07J 63/00
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14705662

C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY

IPC classification:
A61K 31/18, A61K 31/56, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14710687

C-3 ALKYL AND ALKENYL MODIFIED BETULINIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF HIV

IPC classification:
A61K 31/56, A61P 31/18, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14715481

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61K 31/5383, A61P 31/18, C07D 487/04, C07D 487/16, C07D 498/16, C07D 498/22
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14725559

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP14727271

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/429, A61P 31/18, C07D 471/04, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP14718804

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/529, A61P 31/18, C07D 487/04, C07D 498/18, C07D 498/22, C07D 513/22, C07D 515/22
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP14717006

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14734147

NOVEL COMPOUNDS

IPC classification:
A61K 31/427, A61P 35/00, C07K 5/078
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Joseph Lenthall, Mewburn Ellis LLP
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14734146

BENZOTHIOPHENE DERIVATIVES AS ESTROGEN RECEPTOR INHIBITORS

IPC classification:
A61K 31/422, A61K 31/427, A61P 5/30, C07D 409/12, C07D 409/14, C07D 413/14, C07D 417/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Joseph Lenthall, Mewburn Ellis LLP
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11775513

CHEMICAL COMPOUNDS

IPC classification:
A61K 31/554, A61P 3/00, A61P 5/00, C07D 281/10, C07D 417/06, C07F 9/6541
Applicant:
GlaxoSmithKline
Applicant:
GlaxoSmithKline LLC
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP11772961

PYRAZOLE COMPOUNDS ACTING AGAINST ALLERGIC, IMMUNE AND INFLAMMATORY CONDITIONS

IPC classification:
A61K 31/415, A61P 11/00, A61P 29/00, A61P 37/00, C07D 231/38
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11778348

PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING SAME

IPC classification:
A61K 9/00, A61K 31/506, A61K 47/40, A61K 47/48
Applicant:
GlaxoSmithKline Intellectual Property Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14799920

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
C07D 205/04, C07D 215/08, C07D 231/12, C07D 233/38, C07D 233/54, C07D 249/08, C07D 261/08, C07D 263/56, C07D 311/04, C07D 311/58, C07D 317/66, C07D 333/18, C07D 333/28, C07D 401/04, C07D 409/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP12742225

Combination of pazopanib and topotecan

IPC classification:
A61K 31/4745, A61K 31/506, A61K 45/06, A61P 35/00, C07D 231/56
Applicant:
GlaxoSmithKline Intellectual Property Limited
Applicant:
Novartis AG
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Agent:
Markus Gruber, Novartis Pharma AG
Status:
GRANT OF PATENT INTENDED
EP11772962

PYRAZOLE COMPOUNDS ACTING AGAINST ALLERGIC, INFLAMMATORY AND IMMUNE DISORDERS

IPC classification:
A61K 31/415, A61K 31/4155, A61P 11/00, A61P 29/00, A61P 37/00, C07D 231/38, C07D 401/12
Applicant:
Glaxo Group Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14799988

HYDROBROMIDE SALT OFN-(4-CHLORO-2-HYDROXY-3-((3S)-3-PIPERIDINYLSULFONYL)PHENYL-N'-(3-FLUORO-2-METHYLPHENYL)UREA

IPC classification:
A61K 31/4462, A61P 11/00, C07D 211/54
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11726563

MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS

IPC classification:
A61K 31/56, A61P 31/12, A61P 31/18, C07J 63/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
PATENT GRANTED
EP14827868

NRF2 REGULATORS

IPC classification:
C07D 417/10
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15706990

BENZOTHIAZOLE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/429, A61P 31/18, C07D 513/16, C07D 513/22, C07D 515/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15707834

PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/529, A61P 31/18, C07D 211/48, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14709808

PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 498/16
Applicant:
Bristol-Myers Squibb Company
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709381

PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/4545, A61P 31/18, C07D 213/61, C07D 401/04, C07D 401/14, C07D 409/14, C07D 413/14, C07D 417/14
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15707839

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709385

IMIDAZOPYRIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/4745, A61P 31/18, C07D 471/04, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15708065

IMIDAZOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/529, A61P 31/18, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15728950

PYRIDIN-3-YL ACETIC ACID MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15715441

APTAMERS FOR TOPICAL DELIVERY

IPC classification:
A61K 9/107, A61K 38/00, A61K 47/14, A61K 47/26
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15718402

TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY, SUBSTITUTED IN POSITION 3 BY A NON-AROMATIC RING CARRYING A HALOALKYL SUBSTITUENT

IPC classification:
A61K 31/56, A61K 31/58, A61P 31/18, C07C 309/65, C07F 5/02, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15706983

PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 471/22, C07D 495/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15709382

PYRAZOLOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/519, A61P 31/18, C07D 498/16, C07D 498/22
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15729108

CYCLIC DI-NUCLEOTIDES AS MODULATORS OF STING

IPC classification:
A61K 31/665, A61K 31/7084, A61K 39/39, A61P 31/04, A61P 37/04, C07F 9/6574, C07H 19/213
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15745248

SYNTHESIS OF BENZOTHIAZEPINES

IPC classification:
A61K 31/554, A61P 3/10, C07D 281/10
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15762764

HETEROCYCLIC AMIDES AS RIP1 KINASE INHIBITORS AS MEDICAMENTS

IPC classification:
A61K 31/55, A61K 31/551, A61K 31/5513, A61K 31/553, A61K 31/554, A61K 45/06, A61P 17/06, A61P 25/28, A61P 29/00, A61P 37/00, A61P 43/00
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15760003

IMIDAZO[1,2-A]PYRIDINE DERIVATIVES FOR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04, C07D 519/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15775510

LONG ACTING PHARMACEUTICAL COMPOSITIONS

IPC classification:
A61K 9/00, A61K 9/10, A61K 9/50, A61K 31/4985, A61K 31/505, A61K 31/56, A61K 47/10, A61P 31/18
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15798639

OXOLUPENE DERIVATIVES

IPC classification:
A61K 31/56, A61K 31/575, A61P 31/18, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15798640

C17-ARYL SUBSTITUTED BETULINIC ACID ANALOGS

IPC classification:
A61K 31/575, A61K 31/58, A61P 31/18, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15801583

EXTENDED BETULINIC ACID ANALOGS

IPC classification:
A61K 31/56, A61K 31/575, A61K 31/58, A61P 31/18, C07J 63/00
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made
EP15801951

CD38 INHIBITORS AND METHODS OF TREATMENT

IPC classification:
C07D 403/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Stephanie Anne Learoyd, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature